Common Pitfalls to Avoid When Interpreting Clinical Trials, with Deepak Bhatt, MD, MPH, MBA
Deepak Bhatt, MD, MPH, MBA, discusses common pitfalls for clinicians when interpreting trial data based on a presentation he led at ESC Congress 2024.
Philip Mease, MD: Bimekizumab’s Efficacy Over Ustekinumab, Risankizumab in Treating PsA, AxSpA
Mease discussed data supporting FDA approval for the indications in Fall 2024.
ESC Congress 2024 Lipidology Preview, with Professor Kausik Ray
Kausik Ray, MD, discusses what trials and new data in lipidology he is most looking forward to from the upcoming ESC Congress.
Discussing Use of Vaping Among Students, Conversations About Vaccines
During this segment of a recent Lungcast, Mora and Sadeameli speak about 2 key topics: vaping and e-cigarette use among children as well as vaccinations and related misinformation.
Laurence Sperling, MD: Navigating the Changing Landscape of Lipidology
Laurence Sperling, MD, offers perspective on multiple topics within the evolving field of lipid management and dyslipidemia.
Allergies and Asthma During the School Year, with S. Christy Sadeameli, MD, and Juanita Mora, MD
In this Lungcast episode, Mora and Sadeameli highlight Asthma Action Plans as well as Asthma Peak Weak considerations for children in the new school year.
Gil Yosipovitch, MD: Next Steps Following FDA Approval of Nemolizumab for Prurigo Nodularis
Yosipovitch spoke in this interview about the clinical trials leading up to the FDA approval of his nemolizumab for patients with prurigo nodularis.
What the FDA Approval of Nemolizumab Means for Prurigo Nodularis, with Gil Yosipovitch, MD
In this interview, Yosipovitch discusses his team’s findings on nemolizumab and the significance of the drug’s FDA approval for those with prurigo nodularis.
ESC Congress 2024 Clinical Trials to Watch, with Deepak Bhatt, MD, MPH, MBA
Deepak Bhatt, MD, MPH, MBA, discusses 7 trials to watch from hotline or late-breaking sessions at the upcoming European Society of Cardiology Congress 2024.
Impact of Nasal Epinephrine Spray for Patients with Severe Allergies, with Edwin H. Kim, MD
In this interview, Kim speaks about the significance of the FDA approval of neffy for patients who face the threat of anaphylaxis and other severe allergic reactions.
Discussing the Global Prevalence of Seborrheic Dermatitis, with Raj Chovatiya, MD, PhD
In this interview, Chovatiya spoke with the editorial team about the global prevalence findings on patients with seborrheic dermatitis and their implications.
Casey Paleos, MD: Remaining Questions on MDMA-Assisted Therapy in PTSD
In this video series segment, Casey Paleos, MD, provides insight into what he considers to be the most pertinent unanswered questions surrounding MDMA-assisted therapy in PTSD.
Casey Paleos, MD: Potential of Psychedelic Therapies in PTSD Management
In this video series segment, Casey Paleos, MD, discusses his outlook on the potential of psychedelic therapies in PTSD looking forward.
Casey Paleos, MD: Confronting Stigma Associated with MDMA in Therapeutic Context
In this video series segment, Casey Paleos, MD, offers insight into the impact of historic stigma associated with psychedelic therapies on acceptance in psychiatric care.
Casey Paleos, MD: Interpreting Trial Data and Safety for MDMA-Assisted Therapy in PTSD
In this video series segment, Casey Paleos, MD, describes his interpretation of clinical trial data for MDMA-assisted therapy in PTSD as well as his reaction to the FDA PDAC vote in early June.
Casey Paleos, MD: Current Options and Unmet Need in PTSD
In this video series segment, Casey Paleos, MD, provides perspective on the current options and unmet needs in the management of posttraumatic stress disorder.
Brett King, MD, PhD: Value of LEVEL UP Data and Pushing New Standards in Dermatology
Brett King, MD, PhD, discusses the LEVEL UP trial and how it represents the field of dermatology's desire to advance care and advocate for new standards of care.
Janelle Bludhorn, MS, PA-C: How Common Medications Are Impacted by Extreme Heat
This segment of the latest Lungcast featured a discussion about heat and its interplay with various types of common medications.
Jonathan Silverberg, MD, PhD: Treatment Modification Following New Recommendations for Eczema
This interview segment featured Silverberg discussing the AHEAD atopic dermatitis recommendations and their implications for clinicians and patients.
Updates to International Recommendations for Eczema, with Jonathan Silverberg, MD, PhD
Silverberg discusses the new AHEAD recommendations for optimizing atopic dermatitis management, highlighting goals, disease severity assessments, and guidance for escalation.
How to Screen for Heat-Related Illness Risks, with Janelle Bludorn, MS, PA-C
In this Lungcast segment, Bludorn speaks on commonly-seen heat-related illnesses amid a changing climate as well as how to screen for related risks.
Melinda Gooderham, MD: Effects of Roflumilast Foam on Scalp, Body Psoriasis
In this interview, Gooderham highlights the ARRECTOR study findings which led to roflumilast foam’s supplemental new drug application to the FDA.
HCPLive Five at ASRS 2024
Counting down the most impactful news at major medical meetings, it’s the HCPLive Five! This episode focuses on 5 key interviews from the American Society of Retina Specialists (ASRS) 42nd Annual Meeting.
Jordana Fein, MD: Pre-Dose IOP Outcomes After Aflibercept 8 mg for DME
Pre-dose IOP outcomes in eyes with DME receiving aflibercept 8 mg or 2 mg were comparable through Week 48 of the Phase 2/3 PHOTON trial.
Diana Do, MD: Impact of Baseline BCVA on Aflibercept 8 mg Outcomes in DME
A post hoc analysis of PHOTON showed the utility of aflibercept 8 mg in patients with DME, irrespective of baseline visual acuity.
Crisis Point: Improving Diversity in Dermatology
In this episode of Crisis Point, 3 experts in dermatology discuss ways in which those in the field are working to improve visibility of diverse skin types within dermatology education.
Top Gene Therapy News at ASRS 2024
A recap of the 5 most popular topics related to gene therapy in ophthalmology coming from the 42nd American Society of Retina Specialists meeting.
Brett King, MD: Deuruxolitinib Approval and the 'Golden Age' of Alopecia Areata
Brett King, MD, PhD, discusses how the deuruxolitinib approval impacts the treatment landscape of alopecia areata.
Prospect of Psychedelic Therapies in Psychiatry, with Gus Alva, MD
In this part of our 5-part series, Gus Alva, MD discusses the next steps in research for long-term effects and broader applications of MDMA-assisted therapy.
Future Research Priorities for MDMA-Assisted Therapy in PTSD, with Gus Alva, MD
In this part of our 5-part series, Gus Alva, MD explores MDMA’s neurochemical impact and the need for ongoing research.
